Koon Ho Rha Selected Research

Neoplasms (Cancer)

1/2022	Comparing Revo-i and da Vinci in Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Preliminary Propensity Score Analysis of Outcomes.
12/2021	Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
4/2021	Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial.
1/2021	Robot-assisted partial nephrectomy for high-complexity tumors (PADUA score ≥10): Perioperative, long-term functional and oncologic outcomes.
12/2020	Is robot-assisted partial nephrectomy safe for high complexity tumors?
10/2020	Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system.
8/2020	Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.
5/2020	Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients with Localized Pathologic T1N0M0 Stage Disease.
5/2020	Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study.
1/2020	Robot-assisted laparoendoscopic single-site upper urinary tract surgery with da Vinci Xi surgical system: Initial experience.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koon Ho Rha Research Topics

Disease

69	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 04/2007
58	Neoplasms (Cancer) 01/2022 - 05/2005
21	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 05/2005
20	Margins of Excision 02/2022 - 01/2008
11	Neoplasm Metastasis (Metastasis) 08/2020 - 08/2014
9	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 08/2006
7	Carcinoma (Carcinomatosis) 01/2018 - 04/2013
5	Flatulence 01/2021 - 09/2010
5	Hemorrhage 05/2020 - 09/2009
5	Pneumoperitoneum 05/2016 - 05/2009
5	Pain (Aches) 09/2015 - 09/2011
4	Chronic Renal Insufficiency 01/2023 - 01/2016
4	Obesity 01/2020 - 01/2008
4	Intraoperative Complications 06/2012 - 05/2010
3	Ileus 01/2021 - 09/2014
3	Disease Progression 11/2018 - 03/2015
3	Cysts 12/2016 - 05/2010
3	Wounds and Injuries (Trauma) 10/2014 - 01/2011
3	Postoperative Pain 10/2014 - 09/2003
2	Renal Insufficiency (Renal Failure) 05/2019 - 05/2009
2	Urinary Incontinence 01/2018 - 11/2010
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2015
2	Extranodal Extension 08/2016 - 06/2009
2	Ischemia 03/2013 - 02/2013
2	Body Weight (Weight, Body) 03/2010 - 01/2008
2	Transitional Cell Carcinoma 12/2009 - 08/2009
1	Non-Muscle Invasive Bladder Neoplasms 10/2021
1	Carcinogenesis 04/2021
1	Shock 12/2020
1	Overweight 01/2020
1	Vascular System Injuries 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2019
1	Lymphadenopathy 04/2019
1	Reperfusion Injury 01/2017
1	Cardiac Arrhythmias (Arrythmia) 05/2016
1	Postoperative Cognitive Complications 05/2016
1	Adenocarcinoma 01/2016
1	Angiomyolipoma 01/2016
1	Hypertrophy 12/2015
1	Stomach Neoplasms (Stomach Cancer) 04/2015
1	Seminoma 01/2015
1	Cicatrix (Scar) 10/2014

Drug/Important Bio-Agent (IBA)

25	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2010
9	AndrogensIBA 08/2020 - 04/2002
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2015
5	Hormones (Hormone)IBA 04/2021 - 04/2002
3	Androgen Receptors (Androgen Receptor)IBA 12/2021 - 01/2018
2	Messenger RNA (mRNA)IBA 04/2021 - 05/2020
2	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2018
2	CreatinineIBA 05/2019 - 05/2009
2	Indicators and Reagents (Reagents)IBA 09/2014 - 05/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2021
1	CytokinesIBA 04/2021
1	Colloids (Colloid)IBA 01/2021
1	Crystalloid SolutionsIBA 01/2021
1	Sunitinib (Sutent)FDA Link 12/2020
1	Polypropylenes (Polypropylene)IBA 01/2020
1	Chewing Gum (Chewing Gums)IBA 11/2018
1	RadiopharmaceuticalsIBA 01/2018
1	CalciumIBA 10/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017
1	DioxinsIBA 01/2017
1	AntioxidantsIBA 01/2017
1	MineralsIBA 01/2017
1	Persistent Organic PollutantsIBA 01/2017
1	Polychlorinated Biphenyls (PCBs)IBA 01/2017
1	urinastatin (MR 20)IBA 01/2017
1	Dexmedetomidine FDA Link 05/2016
1	Alkaline PhosphataseIBA 03/2015
1	Lipocalin-2IBA 01/2015

Therapy/Procedure

65	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 04/2007
46	Nephrectomy 01/2023 - 12/2004
19	Therapeutics 12/2021 - 06/2009
15	Operative Time 01/2022 - 01/2008
14	Cystectomy 01/2024 - 08/2006
11	Length of Stay 01/2022 - 06/2009
10	Castration 10/2020 - 03/2015
9	Nephroureterectomy 07/2017 - 08/2009
8	Radiotherapy 08/2020 - 06/2002
7	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 08/2009
6	Warm Ischemia 04/2020 - 09/2009
5	Neoadjuvant Therapy 01/2024 - 06/2013
4	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2011
3	Urinary Diversion (Ileal Conduit) 10/2021 - 08/2006
3	Minimally Invasive Surgical Procedures 01/2020 - 09/2003
2	Salvage Therapy 10/2021 - 07/2018
2	Robotic Surgical Procedures 01/2018 - 03/2014
2	Adjuvant Radiotherapy 01/2015 - 06/2010
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2014 - 08/2008
2	Surgical Gloves (Surgical Glove) 09/2011 - 01/2011
2	Adrenalectomy 01/2011 - 05/2010
1	Percutaneous Nephrolithotomy 12/2020
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2020
1	Sutures (Suture) 01/2020
1	Massage (Zone Therapy) 11/2018
1	Metastasectomy 10/2017
1	Time-to-Treatment 10/2017
1	Local Anesthesia 07/2017
1	General Anesthesia 07/2017
1	Aftercare (After-Treatment) 01/2015